Renalytix plc Form 6-K Current Report Filed 2023-02-08

Por um escritor misterioso

Descrição

Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
UBS Group AG Portfolio Holdings
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Stock Market News 2023-05-25
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Stock Market News 2023-05-25
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Mitek Reports Fiscal 2023 Third Quarter Financial Results
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Stock Market News 2023-06-05
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Trinity Delta Two key Phase II results on track for next 12 months - Trinity Delta
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Millennium Management Llc Portfolio Holdings
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
de por adulto (o preço varia de acordo com o tamanho do grupo)